There was no significant difference in FRα staining between the three histological subtypes of mesothelioma, and no difference was observed in the overall survival or time to treatment failure for patients with positive FRα tumours compared with those with negative FRα tumours. The gene discussed is FOLR1; the disease is neoplasm.